A SECRET WEAPON FOR LINK ALTERNATIF MBL77

Not all patients with CLL need therapy. Irrespective of all recent advances, the iwCLL continue to recommends watchful observation for people with asymptomatic disease.86 This suggestion is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each